On Thursday, Shares of Southwest Airlines Co. (NYSE:LUV), gained 3.87% to $36.48.
Southwest Airlines stated its second quarter 2015 results:
- Record quarterly net income, not taking into account special items1, of $691 million, or $1.03 per diluted share. This represented a $206 million enhance from second quarter 2014 and exceeded the First Call consensus estimate of $1.02 per diluted share.
- Record quarterly GAAP2 net income of $608 million, or $.90 per diluted share.
- Record quarterly GAAP operating income of $1.1 billion. Not taking into account special items, record quarterly operating income of $1.1 billion, resulting in an operating margin of 22.5 percent.
- Returned $430 million to Shareholders through dividends and share repurchases during second quarter 2015, and $811 million during first half 2015.
- Return on invested capital, before taxes and not taking into account special items (ROIC)1, for the 12 months ended June 30, 2015, of 28.2 percent, contrast with 17.1 percent for the 12 months ended June 30, 2014.
- Subsequent to June 30, 2015, the Company amended and extended its co-branded credit card agreement with Chase Bank USA, N.A. (Chase), which is predictable to provide generous rewards to the Company’s co-branded credit cardholders and noteworthy future value to the Company’s Shareholders. The Company presently estimates its second half 2015 GAAP operating revenues will enhance about $400 million from the combined impact of the amended agreement and the effect of a change in accounting methodology.
Southwest Airlines Co. operates passenger airlines that provide planned air transportation services in the United States and near-international markets. As of December 31, 2014, it operated 665 Boeing 737 aircraft; and had 12 Boeing 717 aircraft.
Shares of Mylan N.V. (NASDAQ:MYL), declined -1.97% to $66.56, during its last trading session.
Mylan acknowledged the exercise of the full call option by Stichting Preferred Shares Mylan, an independent foundation incorporated under the laws of the Netherlands. The Foundation notified Mylan that it has exercised its call option to acquire 488,388,431 Mylan preferred shares following the Call Option Agreement, dated April 3, 2015, between Mylan and the Foundation.
Mylan N.V., through its auxiliaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company provides generic or branded generic pharmaceutical products in tablet, capsule, injectable, or transdermal patch forms, in addition to active pharmaceutical ingredients (APIs).
Finally, Humana Inc. (NYSE:HUM), ended its last trade with -0.74% loss, and closed at $184.73.
Oak Street Health, and Humana Inc. (HUM), a leading health and well-being company, have recently forged a new value-based agreement, effective June 1, 2015. The agreement aims to bring higher quality and more coordinated care to Medicare Advantage members in the greater Chicago area.
Through this new agreement, Humana and Oak Street Health will work hand-in-hand to enhance the organization’s value-based delivery system, drive integrated care, lower costs and continue to ensure a world-class patient experience.
Established in 2013, Oak Street Health entered the Illinois market with primary care centers in the Edgewater and Portage Park neighborhoods in Chicago with a focus on providing care for Medicare Advantage patients. Recently, the health system has expanded to comprise nine centers in Illinois and by the end of 2015, it will open six more centers throughout the Midwest.
Humana Inc., together with its auxiliaries, operates as a health and well-being company. The company operates through three segments: Retail, Group, and Healthcare Services. The Retail segment provides Medicare and commercial fully-insured medical and specialty health insurance benefits, counting dental, vision, and other supplemental health and financial protection products directly to individuals.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
